Extracellular HMGB1 as Inflammatory Mediator in the Progression of Mycoplasma Gallisepticum Infection

Cells. 2022 Sep 9;11(18):2817. doi: 10.3390/cells11182817.

Abstract

High-mobility group box 1 (HMGB1), a member of damage-associated molecular patterns (DAMPs), is involved in the immune regulation of several infectious diseases. Mycoplasma gallisepticum (MG) infection is proved to cause an abnormal immune response, but the role of HMGB1 in MG-induced chronic respiratory disease (CRD) is unclear. In this study, we found that HMGB1 was released from the nucleus to the extracellular in macrophages upon infection with MG. Extracellular HMGB1 bound to TLR2 activating the NF-κB pathway triggering a severe inflammatory storm and promoting the progression of MG infection. More importantly, TLR4 could be activated by HMGB1 to trigger immune disorders after TLR2 was silenced. This disease process could be interrupted by ethyl pyruvate (EP) inhibition of HMGB1 release or glycyrrhizic acid (GA). Furthermore, treatment of MG-infected chickens with GA significantly alleviated immune organ damage. In conclusion, we demonstrate that HMGB1 is secreted extracellularly to form an inflammatory environment upon MG infection, triggering a further cellular inflammatory storm in a positive feedback approach. Blocking MG-induced HMGB1 release or suppression downstream of the HMGB1-TLR2/TLR4 axis may be a promising novel strategy for the treatment of CRD. Furthermore, this study may provide a theoretical reference for understanding non-LPS-activated TLR4 events.

Keywords: HMGB1; Mycoplasma gallisepticum; NF-κB signaling pathway; TLR2/TLR4; inflammatory cytokine storm.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chickens / metabolism
  • Glycyrrhizic Acid / pharmacology
  • HMGB1 Protein* / metabolism
  • Inflammation Mediators
  • Mycoplasma gallisepticum*
  • NF-kappa B
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4 / metabolism

Substances

  • HMGB1 Protein
  • Inflammation Mediators
  • NF-kappa B
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Glycyrrhizic Acid

Grants and funding

This study was supported by the National Natural Science Foundation of China (Grant No. 31972681), the National Key Research and Development Program of China (2017YFD0501500).